Changes in Serum Insulin-Like Factor 3 during Normal Male Puberty
Open Access
- 1 September 2006
- journal article
- other
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 91 (9) , 3426-3431
- https://doi.org/10.1210/jc.2006-0821
Abstract
Context: Insulin-like factor 3 (INSL3) is produced by the Leydig cells, and in adults, its secretion is dependent on the state of differentiation of these cells, which, in turn, is dependent on LH. However, the secretion and regulation of INSL3 during puberty is unknown. Objective: Our objective was to evaluate INSL3 concentrations during normal male puberty and the relation of INSL3 to LH, FSH, and testosterone. Design and Setting: We conducted a cross-sectional study from January to December 2005 at academic clinics. Patients: Participating in the study were 75 healthy male subjects aged 9.5–17.5 yr, homogeneously distributed into five pubertal groups of 15 according to Tanner stages. Main Outcome Measures: We assessed mean testicular volume and LH, FSH, testosterone, and INSL3 concentrations in relation to age and pubertal stage. Results: We observed an increase of INSL3 and LH levels from Tanner stage 2 to 4, and an increase of FSH from stage 2 to 3. Testosterone levels increased from stage 3 to 4. No differences were seen for all measured hormones between stages 4 and 5. The increase in INSL3 seemed therefore to anticipate the increase in testosterone. However, INSL3 plasma concentrations at pubertal stages 4 and 5 are about one fourth of adult levels, whereas FSH, LH, and testosterone reached adult levels by stage 4. Positive significant correlations were found between INSL3 and LH for all pubertal stages. Conclusions: This study provides information on the physiological dynamics of INSL3, showing that the serum concentrations of this hormone increased progressively throughout puberty under the differentiating action of LH on Leydig cells. INSL3 is therefore confirmed to represent a marker of Leydig cell differentiation and function. However, a prolonged exposure to LH seems to be necessary to reach INSL3 concentrations of adults. A possible use of INSL3 in puberty disorders is promising.Keywords
This publication has 26 references indexed in Scilit:
- Insulin-like factor 3 gene mutations in testicular dysgenesis syndrome: clinical and functional characterizationMolecular Human Reproduction, 2006
- Expression of Insulin-Like Factor 3 Protein in the Rat Testis during Fetal and Postnatal Development and in Relation to Cryptorchidism Induced by in Utero Exposure to Di (n-Butyl) PhthalateEndocrinology, 2005
- GREAT/LGR8 Is the Only Receptor for Insulin-Like 3 PeptideMolecular Endocrinology, 2003
- The INSL3-LGR8/GREAT Ligand-Receptor Pair in Human CryptorchidismJournal of Clinical Endocrinology & Metabolism, 2003
- INSL3/Leydig Insulin-like Peptide Activates the LGR8 Receptor Important in Testis DescentJournal of Biological Chemistry, 2002
- Activation of Orphan Receptors by the Hormone RelaxinScience, 2002
- A transgenic insertion causing cryptorchidism in miceGenesis, 2001
- Relaxin-Like Factor Expression as a Marker of Differentiation in the Mouse Testis and Ovary1Endocrinology, 1998
- Relaxin-like factor: a highly specific and constitutive new marker for Leydig cells in the human testis.Molecular Human Reproduction, 1997
- Structure and expression of Leydig insulin-like peptide mRNA in the sheepMolecular and Cellular Endocrinology, 1996